Safety period: How are the safety period and danger period calculated?

Direct surgery is usually not recommended for stage 2b cervical cancer, and comprehensive treatment such as radiotherapy and chemotherapy is required. Cervical cancer stage 2b means that the tumor has invaded the parametrial tissue but has not reached the pelvic wall. It is locally advanced according to the International Federation of Gynecology and Obstetrics staging standards. The main treatment methods include concurrent chemoradiotherapy, radical radiotherapy or neoadjuvant chemotherapy followed by evaluation of the possibility of surgery.

Patients with stage 2b cervical cancer have large tumors and may be accompanied by lymph node metastasis. It is difficult to completely remove the lesions with direct surgery, and the risk of postoperative recurrence is high. Simultaneous chemoradiotherapy is the preferred option. It uses radiation to kill tumor cells, and at the same time uses chemotherapy drugs such as cisplatin to enhance the efficacy, shrink the tumor and control metastasis. Some patients may be given the opportunity for surgery if their lesions shrink significantly after neoadjuvant chemotherapy, but the indications and risks of surgery need to be evaluated by a multidisciplinary team.

In rare cases, if the patient is insensitive to chemoradiotherapy or has contraindications, and the tumor is limited to unilateral parametrial tissue, an individualized surgical plan may be considered. However, supplementary radiotherapy or chemotherapy is still required after surgery, and close follow-up is required to monitor signs of recurrence. Surgical options may include radical hysterectomy or pelvic lymphadenectomy, but patient tolerance needs to be carefully assessed.

Patients should go to a cancer specialist hospital as soon as possible after diagnosis, and a gynecological oncologist, radiotherapist, etc. will formulate a personalized treatment plan. During the treatment period, nutritional support needs to be strengthened, high-quality protein and vitamins should be supplemented appropriately, and strenuous exercise should be avoided. Regularly review pelvic MRI or PET-CT to evaluate the efficacy, and follow up every 3-6 months for 5 years after treatment to monitor tumor markers and imaging changes.